Expanding the RNA Virus Universe by Scalable Structure-Guided Discovery

The discovery of RNA viruses from metatranscriptomic data remains challenging due to their extreme sequence divergence and frequent lack of conserved motifs. We present Rider, a lightweight two-stage framework that couples fast, structure-informed sequence screening with targeted structural validation. Stage 1 uses a compact 35M-parameter protein language model to prioritize RdRp-like fragments at whole-sample scale, achieving over 44× higher end-to-end screening throughput on commodity hardware. Stage 2 applies structure prediction and Foldseek-based alignment against a dedicated RdRp structure resource (∼200k ESMFold-predicted structures), providing orthogonal evidence for remote homologs. Applied to >10,000 metatranscriptomes spanning marine, freshwater, soil and host-associated microbiomes, Rider matches or outperforms leading tools (e.g., LucaProt, PalmScan) and additionally recovers divergent and truncated sequences. Multiple orthogonal indicators, including structure consistency and low DNA read mapping to corresponding contigs, support genuine RNA origin. In a human IBD cohort, Rider agrees with state-of-the-art calls for clinically relevant RNA viruses while extending discovery to divergent lineages. Rider turns structure-guided homology search into a practical, scalable pipeline for RNA virome discovery.